SCHEMBL7942874

SCHEMBL7942874

Cc1cnc(-c2ccc[nH]2)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.40
KDR P35968 2/20 0.37
CHEK1 O14757 1/20 0.35
PBRM1 Q86U86 1/20 0.34
ABL1 P00519 2/20 0.33
GPBAR1 Q8TDU6 1/20 0.33
POLB P06746 1/20 0.33
PARP1 P09874 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2A6 P11509 1/20 0.32
CCR1 P32246 1/20 0.32
CCR5 P51681 1/20 0.32
CCR8 P51685 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
PDGFRB P09619 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RAB9A P51151 1/20 0.32
ADORA2A P29274 1/20 0.32
CDK5 Q00535 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL27967475 0.83 TDP1 (0.36) KDM4CKDRCHEK1GPBAR1POLB
SCHEMBL23416965 0.76 CCR1 (0.58) KDM4CKDRCHEK1GPBAR1PARP1
SCHEMBL12248376 0.76 KDM4C (0.37) KDM4CKDRCHEK1PARP1PDGFRB
SCHEMBL30354463 0.74 HPGDS (0.53) KDRCHEK1ABL1POLBCYP2A6
SCHEMBL16059998 0.74 HPGDS (0.53) KDRCHEK1ABL1POLBCYP2A6
SCHEMBL30354464 0.74 HPGDS (0.53) KDRCHEK1ABL1POLBCYP2A6
SCHEMBL15219280 0.73 KDM4C (0.45) KDM4CKDRCHEK1PBRM1GPBAR1
SCHEMBL10021907 0.72 CCR1 (0.41) ABL1POLBCYP1A2CYP2A6CCR1
SCHEMBL22940779 0.72 CCR1 (0.58) KDM4CPARP1CYP2A6CCR1CCR8
SCHEMBL1904338 0.72 KDM4C (0.47) KDM4CKDRCHEK1CYP2A6CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237576-A1 2-AMINOPYRIMIDIN-4-ONE AND 2-AMINOPYRIDINE DERIVATIVES BOTH HAVING BACE1-INHIBITING ACTIVITY SHIONOGI & CO., LTD. (JP) 2011-09-29 US disclosed
WO-2010047372-A1 2-AMINOPYRIDIN-4-ONE AND 2-AMINOPYRIDINE DERIVATIVE BOTH HAVING BACE1-INHIBITING ACTIVITY 塩野義製薬株式会社 (JP) 2010-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237576-A1 2-AMINOPYRIMIDIN-4-ONE AND 2-AMINOPYRIDINE DERIVATIVES BOTH HAVING BACE1-INHIBITING ACTIVITY BACE1, APP, BACE2 KDM4C 3116/4885KDR 4039/4885CHEK1 4014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.